{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:41:53Z","timestamp":1762868513895,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jdcr.2021.03.052","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:42:21Z","timestamp":1618965741000},"page":"46-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series"],"prefix":"10.1016","volume":"13","author":[{"given":"Melissa","family":"Peera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2021.03.052_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review","volume":"34","author":"Al-Janabi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jdcr.2021.03.052_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14712598.2020.1727439","article-title":"Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature","volume":"20","author":"Caldarola","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.jdcr.2021.03.052_bib3","doi-asserted-by":"crossref","first-page":"e12751","DOI":"10.1111\/dth.12751","article-title":"Atopic-like dermatitis after secukinumab injection: a case report","volume":"32","author":"Burlando","year":"2019","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.jdcr.2021.03.052_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamadermatol.2019.1268","article-title":"Morphologic switch from psoriasiform to eczematous dermatitis after anti-IL-17 therapy: a case series","volume":"155","author":"Lai","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2021.03.052_bib5","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/ajd.12664","article-title":"Recurrent angular cheilitis after secukinumab injections","volume":"59","author":"Hitaka","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jdcr.2021.03.052_bib6","article-title":"Dyshidrotic eczema in two patients on secukinumab for plaque psoriasis: a case report","volume":"8","author":"Bose","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"issue":"6","key":"10.1016\/j.jdcr.2021.03.052_bib7","doi-asserted-by":"crossref","DOI":"10.5070\/D3256044449","article-title":"Bullous acral eruption related to secukinumab","volume":"25","author":"Blackcloud","year":"2019","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdcr.2021.03.052_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jdcr.2021.03.052_bib9","first-page":"117","article-title":"Dyshidrotic eczema: relevance to the immune response in situ","volume":"1","author":"Abreu-Velez","year":"2009","journal-title":"N Am J Med Sci"},{"issue":"1","key":"10.1016\/j.jdcr.2021.03.052_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2500\/aap.2015.36.3808","article-title":"Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema\/dermatitis syndrome (AEDS): association with clinical severity and phenotype","volume":"36","author":"Leonardi","year":"2015","journal-title":"Allergy Asthma Proc"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:39Z","timestamp":1762474959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262100254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":10,"alternative-id":["S235251262100254X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.03.052","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.03.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}